Trimodal therapy may be an effective alternative to radical cystectomy for recurrent, high-grade T1 bladder cancer, according to a study published in the Journal of Clinical Oncology.

Adding PD-(L)1 inhibitors to chemotherapy improved outcomes, but PD-(L)1 inhibitors alone were no more effective than chemotherapy alone in patients with gastric, gastroesophageal junction, and ...

Americans have the worst health care among the world’s wealthy nations, according to a report from health care think-tank The Commonwealth Fund. The report showed that people in the United States die ...

(HealthDay News) — Axatilimab produces responses in patients with recurrent or refractory graft-vs-host disease (GVHD), according to a study published in The New England Journal of Medicine.

Treatment with ¹⁷⁷Lu-PSMA-617 appears more effective than changing ARPIs for patients with mCRPC whose disease progressed on a prior ARPI.